Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

Phage-antibiotic combinations (PAC) offer a potential solution for treating refractory daptomycin-nonsusceptible (DNS) methicillin-resistant (MRSA) infections. We examined PAC activity against two well-characterized DNS MRSA strains (C4 and C37) and . PACs comprising daptomycin (DAP) ± ceftaroline (...

Celý popis

Podrobná bibliografia

Vydané v:	Antimicrobial agents and chemotherapy Ročník 68; číslo 4; s. e0138823
Hlavní autori:	Kunz Coyne, Ashlan J, Bleick, Callan, Stamper, Kyle, Kebriaei, Razieh, Bayer, Arnold S, Lehman, Susan M, Rybak, Michael J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 03.04.2024
Predmet:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Ceftaroline Cephalosporins - pharmacology Daptomycin - pharmacology Methicillin-Resistant Staphylococcus aureus Microbial Sensitivity Tests daptomycin-nonsusceptible synergy antibiotics bacteriophage MRSA
ISSN:	1098-6596, 1098-6596
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!